Rash
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% (NCT05461456) | OrchestratePharma GmbH | 2022-04-01 |
| Implementation of a Minor Ailment Service in Community Pharmacy Practice (NCT05247333) | Universidad de Granada | 2020-10-01 |
| Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age (NCT02326467) | Celeste Chandonnet | 2016-02-01 |
| 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX (NCT01692626) | West Virginia University | 2012-02-01 |
| Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (NCT00473083) | British Columbia Cancer Agency | 2009-01-01 |
| Sorafenib-induced Hand- Foot Skin Reaction Treatment (NCT00667589) | Northwestern University | 2008-06-01 |
| A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash (NCT00343187) | Allergan | 2006-06-01 |
Track Rash automatically
Every clearance here is in the API, with alerts when new ones post.